Bacteria found in Alzheimer patients' brain tissue helps clarify the effectiveness of infrared phototherapy
Bacteria now identified in the brains of people struggling with memory loss has been established now in the research findings of a research group at the University of Bristol in the UK led by Dr. David Emery. This finding reinforces the position Quietmind has taken around the utility of near infrared light stimulation for the treatment of neurodegeneration. Clinical trials are now underway at Quietmind's research center in Elkins Park, PA. Call for details 610-940-0488
Your comment will be posted after it is approved.
Leave a Reply.
Our team regularly publishes articles and blog posts on the latest research and news coming out of our group and the field in general.